Page last updated: 2024-08-24

atorvastatin and Local Neoplasm Recurrence

atorvastatin has been researched along with Local Neoplasm Recurrence in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Borre, M; Boström, P; Ettala, O; Fode, M; Helminen, M; Koskimäki, J; Kotsar, A; Lehtimäki, T; Löffeler, S; Marttila, T; Murtola, TJ; Pakarainen, T; Raittinen, PV; Rannikko, A; Riikonen, J; Ronkainen, H; Salonen, A; Seikkula, H; Siltari, A; Tammela, T; Østergren, P1
Li, Q; Liu, S; Tang, X; Xu, W; Yang, F1
Hong, JH; Jeong, IG; Kim, CS; Lim, B; Lim, JH; Yun, SC1
Gao, J; Gao, Y; He, X; He, Y; Li, K; Liu, S; Ma, Q; Pan, W; Qi, Y; Song, W; Wei, L; Xu, J; Xu, P; Xu, X; Yang, Y; Yin, W; Yuan, X; Zhang, J1

Trials

2 trial(s) available for atorvastatin and Local Neoplasm Recurrence

ArticleYear
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
    BMJ open, 2022, 04-29, Volume: 12, Issue:4

    Topics: Androgen Antagonists; Androgens; Atorvastatin; Cholesterol; Clinical Trials, Phase III as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic

2022
Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 09-15, Volume: 27, Issue:18

    Topics: Aged; Atorvastatin; Chemotherapy, Adjuvant; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatectomy; Prostatic Neoplasms

2021

Other Studies

2 other study(ies) available for atorvastatin and Local Neoplasm Recurrence

ArticleYear
Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma.
    Medicine, 2023, Sep-29, Volume: 102, Issue:39

    Topics: Activities of Daily Living; Atorvastatin; Hematoma; Hematoma, Subdural, Chronic; Humans; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Treatment Outcome

2023
Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
    BioMed research international, 2019, Volume: 2019

    Topics: Animals; Apoptosis; Atorvastatin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Prognosis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; rhoB GTP-Binding Protein; Signal Transduction; Up-Regulation; Xenograft Model Antitumor Assays

2019